Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma

Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high mortality worldwide. Accumulating researches have indicated that long non‑coding RNAs (lncRNAs) are involved in varies human cancers, including HCC. Nevertheless, the specific molecular mechanism...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: ZhenYu Feng, ZhenYu Ye, JiaMing Xie, Wei Chen, Wei Li, ChunGen Xing
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
YY1
Acceso en línea:https://doaj.org/article/81b5776956924c9880a35fff1b2114a5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:81b5776956924c9880a35fff1b2114a5
record_format dspace
spelling oai:doaj.org-article:81b5776956924c9880a35fff1b2114a52021-12-05T12:06:09ZStudy on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma10.1186/s13062-021-00312-81745-6150https://doaj.org/article/81b5776956924c9880a35fff1b2114a52021-12-01T00:00:00Zhttps://doi.org/10.1186/s13062-021-00312-8https://doaj.org/toc/1745-6150Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high mortality worldwide. Accumulating researches have indicated that long non‑coding RNAs (lncRNAs) are involved in varies human cancers, including HCC. Nevertheless, the specific molecular mechanism of lncRNA lysyl oxidase like 1 antisense RNA 1 (LOXL1-AS1) in HCC is still unclear. Methods LOXL1-AS1 expression was tested via qRT-PCR in HCC cells. Functional and mechanism assays were respectively done to evaluate the biological functions of HCC cells and the potential interaction of LOXL1-AS1 and other factors. Results We discovered that LOXL1-AS1 was high expressed in HCC cells. Inhibition of LOXL1-AS1 repressed cell proliferation, migration and invasion, but enhanced cell apoptosis in HCC. Further, miR-3614-5p was proven to be sponged by LOXL1-AS1. Additionally, Yin Yang 1 (YY1) was proven as the target gene of miR-3614-5p, and YY1 depletion could repress HCC cell malignant behaviors. YY1 could also transcriptionally activate LOXL1-AS1 expression. In rescue assays, we confirmed that overexpression of YY1 or miR-3614-5p inhibition could reverse the suppressive effects of LOXL1-AS1 silence on the malignant behaviors of HCC cells. Conclusion In short, LOXL1-AS1/miR-3614-5p/YY1 forms a positive loop in modulating HCC cell malignant behaviors.ZhenYu FengZhenYu YeJiaMing XieWei ChenWei LiChunGen XingBMCarticleHepatocellular carcinomaLOXL1-AS1miR-3614-5pYY1Biology (General)QH301-705.5ENBiology Direct, Vol 16, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Hepatocellular carcinoma
LOXL1-AS1
miR-3614-5p
YY1
Biology (General)
QH301-705.5
spellingShingle Hepatocellular carcinoma
LOXL1-AS1
miR-3614-5p
YY1
Biology (General)
QH301-705.5
ZhenYu Feng
ZhenYu Ye
JiaMing Xie
Wei Chen
Wei Li
ChunGen Xing
Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
description Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high mortality worldwide. Accumulating researches have indicated that long non‑coding RNAs (lncRNAs) are involved in varies human cancers, including HCC. Nevertheless, the specific molecular mechanism of lncRNA lysyl oxidase like 1 antisense RNA 1 (LOXL1-AS1) in HCC is still unclear. Methods LOXL1-AS1 expression was tested via qRT-PCR in HCC cells. Functional and mechanism assays were respectively done to evaluate the biological functions of HCC cells and the potential interaction of LOXL1-AS1 and other factors. Results We discovered that LOXL1-AS1 was high expressed in HCC cells. Inhibition of LOXL1-AS1 repressed cell proliferation, migration and invasion, but enhanced cell apoptosis in HCC. Further, miR-3614-5p was proven to be sponged by LOXL1-AS1. Additionally, Yin Yang 1 (YY1) was proven as the target gene of miR-3614-5p, and YY1 depletion could repress HCC cell malignant behaviors. YY1 could also transcriptionally activate LOXL1-AS1 expression. In rescue assays, we confirmed that overexpression of YY1 or miR-3614-5p inhibition could reverse the suppressive effects of LOXL1-AS1 silence on the malignant behaviors of HCC cells. Conclusion In short, LOXL1-AS1/miR-3614-5p/YY1 forms a positive loop in modulating HCC cell malignant behaviors.
format article
author ZhenYu Feng
ZhenYu Ye
JiaMing Xie
Wei Chen
Wei Li
ChunGen Xing
author_facet ZhenYu Feng
ZhenYu Ye
JiaMing Xie
Wei Chen
Wei Li
ChunGen Xing
author_sort ZhenYu Feng
title Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_short Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_full Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_fullStr Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_full_unstemmed Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
title_sort study on the mechanism of loxl1-as1/mir-3614-5p/yy1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma
publisher BMC
publishDate 2021
url https://doaj.org/article/81b5776956924c9880a35fff1b2114a5
work_keys_str_mv AT zhenyufeng studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT zhenyuye studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT jiamingxie studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT weichen studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT weili studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
AT chungenxing studyonthemechanismofloxl1as1mir36145pyy1signalaxisinthemalignantphenotyperegulationofhepatocellularcarcinoma
_version_ 1718372265791324160